ISRCTN11113396已完成不适用
Impact of glucose intolerance on glucose-induced blood pressure regulation in young overweight/obese humans
niversity of Fribourg - Faculty of Science0 个研究点目标入组 40 人开始时间: 2016年7月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Male
入选标准
- •1. Healthy
- •2. Non-smokers
- •3. BMI between 18 and 39.9 kg/m2
- •4. 20-45 years old
排除标准
- •1. Participants diagnosed as diabetics based on the following criteria: fasting glucose levels equal to or exceeds 126 mg/dL (7.0 mmol/L), and b) 2-h glucose equal to or exceeds 200 mg/dL (11.1 mmol/L)
- •2. Any medical condition which could interfere with the measured variables, e.g. cardiovascular-, gastrointestinal-, neurological-, and overt metabolic disorders
- •3. Subjects under current medication (either for acute or chronic illnesses)
- •4. Competition athletes, smokers, or overtly sedentary, or have eating disorders
- •5. Subjects who fear or have adverse reactions to cannulation
研究者
相似试验
招募中
不适用
Investigation of impaired glucose tolerance using continuous glucose monitoring in patients with chronic heart failureChronic Heart FailureJPRN-UMIN000010263St. Marianna University School of Medicine200
进行中(未招募)
1 期
Treatment of latent tuberculosis - Evaluation of the effect on sugar metabolism and inflammatioEUCTR2020-001173-69-DKPernille Ravn220
已完成
不适用
Clinical investigation of Glucose Intolerance in Patients with PheochromocytomapheochromocytomaJPRN-UMIN000034090Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital12
已完成
不适用
A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)Impaired glucose tolerance (IGT)JPRN-UMIN000001109Takeda Pharmaceutical Company Limited1,782
招募中
2 期
Does exogenous glucose-dependent insulinotropic polypeptide (GIP) effect gastric emptying and glycaemic response to small intestinal nutrient in critically ill patients?Blood Glucose ControlCritical illnessMetabolic and Endocrine - Other metabolic disordersACTRN12612000488808Adam Deane25
